Clinical Trials & Results
Search or filter the listing below to find a trial or results of a completed trial.
Showing 7 of 7 Results
All Results
No results found
Please change the filter settings to find the product(s) you are looking for. You can also use the search function to look up a product.
Clear Filters
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for Episodic Migraine
- Condition(s):
- Migraine
- Status:
- Completed
- Requirements:
- 18 Years to 70 Years
- Interventions:
- Drug: Fremanezumab | Drug: Placebo
Efficacy and Safety of 2 Doses of TEV-48125 Versus Placebo for the Prevention of Chronic Migraine
- Condition(s):
- Migraine
- Status:
- Completed
- Requirements:
- 18 Years to 70 Years
- Interventions:
- Drug: Fremanezumab | Drug: Placebo
Efficacy and Safety of Subcutaneous Administration of Fremanezumab for Migraine
- Condition(s):
- Migraine
- Status:
- Completed
- Requirements:
- 18 Years to 70 Years
- Interventions:
- Drug: Fremanezumab | Drug: Placebo
Expanded Access Program for Patients With Migraine
- Condition(s):
- Migraine
- Status:
- No longer available
- Requirements:
- 18 Years to 70 Years
- Interventions:
- Drug: Fremanezumab
Fremanezumab in Preventing Episodic Migraine in Patients 6 to 17 Years of Age
- Condition(s):
- Migraine
- Status:
- Recruiting
- Requirements:
- 6 Years to 17 Years
- Interventions:
- Drug: Fremanezumab | Drug: Placebo
Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Patients 6 to 17 Years
- Condition(s):
- Migraine
- Status:
- Recruiting
- Requirements:
- 6 Years to 17 Years
- Interventions:
- Drug: Fremanezumab | Drug: Placebo
Study to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents
- Condition(s):
- Migraine
- Status:
- Recruiting
- Requirements:
- 6 Years to 17 Years
- Interventions:
- Drug: Fremanezumab
